Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Indopoly Swakarsa Industry Tbk (IPOL) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Indopoly Swakarsa Industry TbkTrade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Indopoly Swakarsa Industry Tbk — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Indopoly Swakarsa Industry Tbk trades at Rp107 (market cap 689.44B, 50.2K 24h volume). The key difference: Indopoly Swakarsa Industry Tbk is far larger — about 2.2× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 50.2K). Which is the better fit depends on your goals.

DGNSIPOL
Market Cap
310.75B689.44B
Volume
963.6K50.2K
Lot
9.64K502
Turnover
217.67M5.32M
Average Price
225.89105.97
Value
217.67M5.32M
Indicative Equilibrium Price
226107
Indicative Equilibrium Volume
1K52

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
IPOL
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Indopoly Swakarsa Industry Tbk

PT Indopoly Swakarsa Industry (the company) was established on 24 Mar 1995 based on Notaries Deed No. 114 and the deed of establishment was approved by the the Ministry of Justice dated Dec 22, 1995. The Company’s articles of association has been amended several times, most recently by notarial deed No. 5 of Popie Savitri, S.H., dated Mar 1, 2010, concerning among others, the change in the Company’s name, and public offering.

Read more on IPOL